Lv1
88 积分 2023-01-10 加入
Progress of CD47 immune checkpoint blockade agents in anticancer therapy: a hematotoxic perspective
1个月前
已完结
Obinutuzumab combined with lenalidomide for relapsed or refractory follicular B-cell lymphoma (GALEN): a multicentre, single-arm, phase 2 study
1个月前
已完结
Unveiling the molecular and immunological drivers of antibody-drug conjugates in cancer treatment
3个月前
已完结